Coloscopy.com — A patient reference
01 — Understanding the procedure

Judging the quality of a coloscopy

In short

Two coloscopies are not always equal. A good examination reaches the far end of the colon, withdraws slowly enough to inspect every fold, and is performed on a bowel that was clean enough to see. These things are measured. The single most studied number is the adenoma detection rate — the proportion of a clinician's screening examinations in which at least one precancerous polyp is found — and higher rates are associated with fewer cancers appearing in the years after a normal test. You are entitled to ask about these measures, and a confident unit will share them.

What this page covers

The handful of quality measures that have been shown to matter for outcomes, what each one means in plain terms, the benchmarks the professional societies now set, and how to ask about them without needing to be an expert.

  • Adenoma detection rate — the headline number
  • Caecal intubation rate — whether the whole colon was seen
  • Withdrawal time — whether the inspection was unhurried
  • Bowel-preparation adequacy — whether the view was clean
  • Other measures, and what to ask

Why quality is measurable at all

A coloscopy is operator-dependent in a way that, say, a blood test is not. The instrument is the same from room to room, but how far it reaches, how carefully it is withdrawn, and how reliably small or flat lesions are noticed varies between clinicians and between units. Because colorectal cancer that appears within a few years of a normal coloscopy — a post-coloscopy colorectal cancer — is often traceable to a missed or incompletely removed lesion, the profession has settled on a small set of process measures that predict it. They are not bureaucratic box-ticking; the strongest of them tracks real differences in later cancer.

Adenoma detection rate

The adenoma detection rate, or ADR, is the proportion of a clinician's screening coloscopies in which at least one adenoma — the common precancerous polyp — is found and confirmed by the laboratory. It is the most important single quality measure because it has been linked directly to outcomes: in a large study, each one-percentage-point rise in a clinician's ADR was associated with a measurable fall in the risk of a patient later developing colorectal cancer. A higher ADR means a more careful, more complete look.

In their 2024 update, the American College of Gastroenterology and the American Society for Gastrointestinal Endoscopy raised the recommended target. For screening, surveillance, and diagnostic coloscopies in adults over 45, the benchmark is now an ADR above 35 percent overall (it was previously set at 25 percent, with separate figures for men and women). For coloscopies performed because a stool test was positive — where the chance of finding something is higher — the target is above 50 percent. A related newer measure, the sessile serrated lesion detection rate, has a target above 6 percent, reflecting attention to the flat, pale lesions that are easier to miss.

One caution: ADR is a property of a clinician across many examinations, not of your single test. A high-ADR endoscopist who finds nothing in your colon has very probably given you a thorough examination; it does not mean they failed to find something. The number describes habits, not your result.

Caecal intubation rate

A complete coloscopy reaches the caecum — the pouch at the start of the large bowel where the small intestine joins — and ideally photographs landmarks there to prove it. The right side of the colon is where some of the most consequential lesions sit, so a test that stops short has not done its job. The caecal intubation rate is the proportion of a clinician's examinations that reach this point; the benchmark is at or above 95 percent for screening examinations. Your own report should state that the caecum was reached, usually with a photograph of the appendix opening or the ileocaecal valve. If it was not reached, the report should say why and what is planned instead — see when the exam is incomplete or repeated.

Withdrawal time

The careful inspection happens on the way out, not on the way in. Once the scope reaches the caecum, the endoscopist withdraws it slowly, flattening folds and washing the wall to expose lesions hiding behind them. Average withdrawal time — measured across negative examinations where no biopsy or removal slowed things down — is a proxy for how unhurried that inspection is. The 2024 update extended the recommended average to above eight minutes, lengthened from the long-standing six-minute figure as evidence accumulated that a slower withdrawal finds more. This is an average across a clinician's practice, not a stopwatch target for your individual test; a thorough removal of several polyps can legitimately take much longer, and a genuinely pristine, short colon can take less.

Bowel-preparation adequacy

None of the above helps if the view is obscured. A clinician can only find what they can see, and residual stool hides lesions. Units track the proportion of outpatients whose preparation was rated adequate — clean enough to detect polyps larger than five millimetres — with a benchmark above 90 percent. Your report may name the scale used, most often the Boston Bowel Preparation Scale, which scores each of the three segments of the colon from 0 to 3. A total at or above 6, with no segment below 2, is generally considered adequate. If your preparation was poor, the recommended interval to the next test is shortened, because confidence in a clean result is lower. The pages on preparation and how to tell the prep has worked cover your side of this.

Other measures worth knowing

  • Appropriate interval recommendations. A quality unit recommends the next test at a guideline-concordant interval — neither too soon (which wastes resource and adds risk) nor too late. The target is that 90 percent of recommendations match the guideline for the findings. See surveillance intervals.
  • Complete polyp removal. A polyp left partly behind can regrow, sometimes with worse biology. Endoscopists increasingly photograph the cleared site and, for larger lesions, take margin biopsies to confirm completeness.
  • Complication rates. Units track their own rates of perforation and significant bleeding. These should be very low — see risks and benefits in numbers — and a unit that measures them is a unit paying attention.

What to ask your clinician

  • What is your adenoma detection rate, or the unit's?
  • What proportion of your examinations reach the caecum?
  • Will my report confirm that the whole colon was seen, with photographs?
  • Which bowel-preparation scale do you use, and what was my score?
  • If my preparation is rated inadequate, what will you recommend?
  • How does the unit track perforation and bleeding, and what are its rates?

Common worries, briefly addressed

Is it rude to ask my doctor for their ADR?

No. It is a recognised quality measure that endoscopists are expected to monitor, and many are glad to discuss it. If a unit is offended or cannot answer, that is itself information. You are asking the same question the profession asks of itself.

My doctor found no polyps. Was the test low quality?

Not at all — many normal colons contain no polyps, especially at a first screening. ADR is a rate across many patients, not a verdict on your test. A careful examination of a polyp-free colon is exactly what it should be.

How do I know my whole colon was examined?

Ask for, or read, your procedure report. It should state that the caecum was reached and usually include landmark photographs. If it does not, ask the unit to confirm.

The withdrawal felt very quick. Should I worry?

Patients are usually sedated and have little reliable sense of timing. The relevant figure is the clinician's average across negative examinations, not your perception. If you are concerned, the report and the unit's quality data are better guides than the memory of the day.

Sources

  • American College of Gastroenterology and American Society for Gastrointestinal Endoscopy — quality indicators for colonoscopy (2024 update)
  • American Society for Gastrointestinal Endoscopy — adenoma detection rate and post-colonoscopy colorectal cancer
  • European Society of Gastrointestinal Endoscopy — performance measures for lower gastrointestinal endoscopy
  • British Society of Gastroenterology — coloscopy quality and key performance indicators
  • Published cohort studies linking adenoma detection rate to interval colorectal cancer

Related pages